© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
July 08, 2020
Type 2 diabetes risk prediction is improved by observing changes in gut bacteria, a study finds.
July 06, 2020
Xeris Pharmaceuticals’ new glucagon injection (Gvoke HypoPen), a ready-to-use glucagon formulation in a premixed autoinjector, is now available by prescription.
July 02, 2020
Individuals recently diagnosed with type 2 diabetes were more likely to die from heart failure than any other cardiovascular disease, a study found.
July 01, 2020
The CDC has identified the pharmacy sector as a key partner in offering its lifestyle change-based program for patients with high risk for type 2 diabetes.
June 23, 2020
The first and only one of its kind, metoclopramide nasal spray offers relief to often debilitating symptoms of the gastrointestinal disease.
June 19, 2020
In response to the study, the NYC Department of Health is pursuing large-scale implementation of this approach, targeting diabetes hot spots across the city through public health messaging, mailed print materials, and Care Calls.
June 18, 2020
“We know that if we don’t address these potential difficulties before they occur, the burden to families can be devastating and the health care costs are tremendous.”
A study presented at the American Diabetes Association 80th Annual Scientific Sessions examined the impact of digital Diabetes Self-Management Support systems.
June 15, 2020
Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.
A study presented during the American Diabetes Association 80th Scientific Sessions focused on assessing preference and attitudes from patients with diabetes, their caregivers, and acquaintances.